Ashley Treatment

Last updated
Ashley X
Ashley x.jpg
Ashley X as a baby
Born1997 (age 25–26)
Seattle area

The Ashley Treatment refers to a controversial set of medical procedures performed on an American child, "Ashley X". Ashley, born in 1997, has severe developmental disabilities due to static encephalopathy; she is assumed to be at an infant level mentally, but continues to grow physically. The treatment included growth attenuation via high-dose estrogens, hysterectomy, bilateral breast bud removal, and appendectomy. [1] In June 2016, after 18 years of searching, Ashley's condition was determined to be the result of a de novo (not inherited, i.e. a mutation) and non-mosaic single-nucleotide polymorphism in the GRIN1 gene, [2] which is implicated in neurotransmission.

Contents

The principal purpose of the treatment was to improve Ashley's quality of life by limiting her growth in size, eliminating menstrual cramps and bleeding, and preventing discomfort from large breasts. The combination of the surgery and the estrogen therapy attracted much public comment and ethical analysis in early 2007, both supportive and condemning. [3] [4]

Ashley's parents granted their first written interview to CNN Health in March 2008, [5] and their second to The Guardian in March 2012. [6] In addition, The Guardian published two interviews with mothers of a girl [7] and a boy [8] who had completed the treatment. A 2014 TV program and article tell the similar story of a girl in New Zealand. [9] [10] A survey on growth attenuation among pediatric endocrinologists was published in July 2015. [11] [12]

Background

Ashley was born with a severe brain impairment of genetic cause, [2] termed a "static encephalopathy" because it does not improve. Although she sleeps and awakens, and breathes on her own, she is unable to raise her head, sit up, hold an object, walk, or talk, and must be tube-fed. Nonetheless, she is alert and responsive to her environment, particularly enjoying the music of Andrea Bocelli. Her parents have nicknamed Ashley "Pillow Angel", because she always remains where she is placed, which is usually on a pillow. [2]

In 2004 when Ashley was six and a half years old, she began to show signs of puberty [2] and her parents and doctors began to anticipate a variety of issues common in children with severe neurological impairments. As these children grow larger, it takes more strength to move them and provide basic bodily care, raising the risk of pressure sores from immobility. Precocious puberty is common in children with various forms of severe brain damage. The early appearance of secondary sexual characteristics is often distressing to parents and caretakers. Many parents of severely disabled children explore possible ways to avoid having to deal with menstruation and fertility in a diapered child.[ citation needed ] A variety of treatments have been used over the last several decades to deal with these issues.

In July 2004, Ashley had a hysterectomy (to prevent menstruation) and surgical removal of her nascent breast buds (to prevent development). She also underwent an appendectomy (because Ashley wouldn't be able to vocalize symptoms). The surgery was performed at Seattle's Children's Hospital and Regional Medical Center. In addition, in December 2006 she completed estrogen therapy through dermal patches, which sped up the natural closure of her growth plates.

Ashley's story first broke in October 2006, in the Archives of Pediatrics & Adolescent Medicine . In January 2007, her parents, who wish to remain anonymous, set up a blog to explain their reasoning for their decision and to share their story with families of other children who might benefit. [2]

Arguments for the treatment

The parents state that they sought such treatment for the best interests of their daughter, namely, to enable them to personally continue constant care for her at home; to maximize her inclusion in family activities; to avoid the cramps and discomfort associated with menstruation; and to avoid the discomfort from large breasts (which runs in Ashley's family) while lying down or strapped in the chest area while in her wheelchair. Furthermore, they cited additional side benefits: to reduce the risk of bedsores; to prevent breast cancer and fibrocystic growth (both of which have occurred in her family); to prevent pregnancy; and to prevent appendicitis, which occurs in 5% of the population and which would be difficult to diagnose in Ashley as she would be unable to communicate the symptoms. They also believe that without secondary sexual characteristics, Ashley will be less vulnerable to sexual abuse [2] by future caregivers when her parents will no longer be able to care for her.

In an article published in June 2009 on Growth Attenuation, two pediatric endocrinologist and two bioethicists concluded as follows:

Our analysis suggests that growth attenuation is an innovative and sufficiently safe therapy that offers the possibility of an improved quality of life for nonambulatory children with profound cognitive disability and their families. Pediatricians and other care providers should include discussion of these options as part of anticipatory guidance around the age of 3 years so that, if elected, potential clinically meaningful benefits of growth-attenuation therapy can be realized. [13]

The two bioethicists from the previous article also published an article in January 2010 cataloging and countering the criticisms that targeted the Ashley Treatment, and concluded as follows:

The purpose of this paper is to provide a brief review of the [Ashley Treatment] case and the issues it raised, then address 25 distinct substantive arguments that have been proposed as reasons that Ashley's treatment might be unethical. We conclude that while some important concerns have been raised, the weight of these concerns is not sufficient to consider the interventions used in Ashley's case to be contrary to her best interests, nor are they sufficient to preclude similar use of these interventions in the future for carefully selected patients who might also benefit from them. [14]

Results

After a year, Ashley's parents considered her treatment a success: She will never experience menstrual discomfort and cramps, she will always be flat chested and avoid breast related discomfort and other issues, and with her growth plates closed, she has reached her adult height of 53 inches (135 cm, or 4 ft 5 in) and weight of 63 pounds (29 kg), an estimated reduction of her potential height and weight of 20% and 40%, respectively.[ tone ] [15]

Reactions

In the United States, Arthur Caplan, of the University of Pennsylvania's Center for Bioethics, has criticized the Ashley Treatment in an MSNBC editorial, arguing that it is "a pharmacological solution for a social failure—the fact that American society does not do what it should to help severely disabled children and their families." [16] Three renowned bioethicists spoke in support of the treatment and discussed different aspects of it in opinion statements presented by Scientific American. [17]

Disability rights advocates, including Not Dead Yet [18] and Feminist Response in Disability Activism (FRIDA), called the treatment "invasive medical experimentation", "mutilation", "desexualization", and a violation of Ashley's human rights. FRIDA called on the American Medical Association to condemn the Ashley Treatment. [19] The Disability Rights Education and Defense Fund (DREDF) declared, "we hold as non-negotiable the principle that personal and physical autonomy of all people with disabilities be regarded as sacrosanct". [20]

Ashley's parents reported that 95% of the 5,000 emails they received were in support of the treatment, many of these testimonies and support emails are posted on Ashley's blog. [2] The parents indicated that there was especially strong support among parents and caregivers of children with similar conditions to Ashley's, those who have the direct experience. They cite several ethicists in support of the treatment, including George Dvorsky, [21] Peter Singer, [22] Norm Fost, [23] and Doug Diekema. [24]

In the United Kingdom, the British Medical Association stated, "If a similar case occurred in the UK, we believe it would go to court and whatever decision was ruled would be in the best interests of the child." Dr. Peter Hindmarsh, Professor of Paediatric Endocrinology at Great Ormond Street Hospital was troubled by the treatment decision being taken by a hospital ethics committee. "'I am not sure the ethics committee was the right place to decide,' he said, adding that it was not clear who represented the child's interests when it went before the committee." [25]

In Canada, ethicist Arthur Schafer's nationwide opinion piece [26] defending the operation as justifiable considering Ashley's comfort engendered criticism from disability rights activists such as Dave Hingsburger [27] of the York Central Hospital and Keenan Wellar from the LiveWorkPlay self-advocacy organization. In a rebuttal, [28] Wellar attacked the notion that Ashley's limited mental abilities justified the decisions made on her behalf: "Infants have human rights even though they can't speak for themselves. Why should Ashley have received any less consideration?"

On May 8, 2007, an investigative report done by Disability Rights Washington (formerly The Washington Protection and Advocacy System) in conjunction with The Utah Disability Law Center criticized the hospital that performed this controversial procedure for violating Washington State law, [29] which is disputed by the family's attorney.

Related Research Articles

<span class="mw-page-title-main">Turner syndrome</span> Chromosomal disorder in which a female is partially or completely missing an X chromosome

Turner syndrome (TS), also known as 45,X, or 45,X0, is a genetic disorder caused by a sex chromosome monosomy, compared to the two sex chromosomes in most people, it only affects women. Signs and symptoms vary among those affected. Often, a short and webbed neck, low-set ears, low hairline at the back of the neck, short stature, and swollen hands and feet are seen at birth. Typically, those affected do not develop menstrual periods or breasts without hormone treatment and are unable to have children without reproductive technology. Heart defects, diabetes, and low thyroid hormone occur in the disorder more frequently than average. Most people with Turner syndrome have normal intelligence; however, many have problems with spatial visualization that may be needed in order to learn mathematics. Vision and hearing problems also occur more often than average.

Aversion therapy is a form of psychological treatment in which the patient is exposed to a stimulus while simultaneously being subjected to some form of discomfort. This conditioning is intended to cause the patient to associate the stimulus with unpleasant sensations with the intention of quelling the targeted behavior.

Growth hormone therapy refers to the use of growth hormone (GH) as a prescription medication—it is one form of hormone therapy. Growth hormone is a peptide hormone secreted by the pituitary gland that stimulates growth and cell reproduction. In the past, growth hormone was extracted from human pituitary glands. Growth hormone is now produced by recombinant DNA technology and is prescribed for a variety of reasons. GH therapy has been a focus of social and ethical controversies for 50 years.

Delayed puberty is when a person lacks or has incomplete development of specific sexual characteristics past the usual age of onset of puberty. The person may have no physical or hormonal signs that puberty has begun. In the United States, girls are considered to have delayed puberty if they lack breast development by age 13 or have not started menstruating by age 15. Boys are considered to have delayed puberty if they lack enlargement of the testicles by age 14. Delayed puberty affects about 2% of adolescents.

<span class="mw-page-title-main">Prolactinoma</span> Medical condition

A prolactinoma is a tumor (adenoma) of the pituitary gland that produces the hormone prolactin. It is the most common type of functioning pituitary tumor. Symptoms of prolactinoma are due to abnormally high levels of prolactin in the blood (hyperprolactinemia), or due to pressure of the tumor on surrounding tissues. Based on size, a prolactinoma can be classified as a microprolactinoma or a macroprolactinoma.

Developmental disability is a diverse group of chronic conditions, comprising mental or physical impairments that arise before adulthood. Developmental disabilities cause individuals living with them many difficulties in certain areas of life, especially in "language, mobility, learning, self-help, and independent living". Developmental disabilities can be detected early on and persist throughout an individual's lifespan. Developmental disability that affects all areas of a child's development is sometimes referred to as global developmental delay.

The Institutes for The Achievement of Human Potential (IAHP), founded in 1955 by Glenn Doman and Carl Delacato, provide literature on and teaches a controversial patterning therapy, which the Institutes promote as improving the "neurologic organization" of "brain injured" and mentally impaired children through a variety of programs, including diet and exercise. The Institutes also provides extensive early-learning programs for "well" children, including programs focused on reading, mathematics, language, and physical fitness. It is headquartered in Philadelphia, Pennsylvania, with offices and programs offered in several other countries. Pattern therapy for patients with neuromuscular disorders was first developed by neurosurgeon Temple Fay in the 1940s. Patterning has been widely criticized and multiple studies have found the therapy ineffective.

<span class="mw-page-title-main">Breast hypertrophy</span> Human disease

Breast hypertrophy is a rare medical condition of the breast connective tissues in which the breasts become excessively large. The condition is often divided based on the severity into two types, macromastia and gigantomastia. Hypertrophy of the breast tissues may be caused by increased histologic sensitivity to certain hormones such as female sex hormones, prolactin, and growth factors. Breast hypertrophy is a benign progressive enlargement, which can occur in both breasts (bilateral) or only in one breast (unilateral). It was first scientifically described in 1648.

<span class="mw-page-title-main">Judge Rotenberg Educational Center</span> Controversial American special education institution

Growth attenuation is an elective medical treatment which involves administering estrogen to cause closure of the epiphyses of the bones, resulting in a reduced adult height. Since the 1960s this treatment has been performed primarily on children growing toward an adult height considered unacceptably excessive by their parents and doctors. The cultural consensus of what is considered an excessive height justifying treatment has differed in Europe and North America and has risen over the last 4 decades.

Alternative therapies for developmental and learning disabilities include a range of practices used in the treatment of dyslexia, ADHD, autism spectrum disorders, Down syndrome and other developmental and learning disabilities. Treatments include changes in diet, dietary supplements, biofeedback, chelation therapy, homeopathy, massage and yoga. These therapies generally rely on theories that have little scientific basis, lacking well-controlled, large, randomized trials to demonstrate safety and efficacy; small trials that have reported beneficial effects can be generally explained by the ordinary waxing and waning of the underlying conditions.

Child euthanasia is a form of euthanasia that is applied to children who are gravely ill or have significant birth defects. In 2005, the Netherlands became the first country since the end of the Third Reich to decriminalize euthanasia for infants with hopeless prognosis and intractable pain. Nine years later, Belgium amended its 2002 Euthanasia Act to extend the rights of euthanasia to minors. Like euthanasia, there is world-wide public controversy and ethical debate over the moral, philosophical and religious issues of child euthanasia.

<span class="mw-page-title-main">Kennedy Krieger Institute</span> Hospital in Maryland, United States

The Kennedy Krieger Institute is a nonprofit, 501(c)(3) tax-exempt, Johns Hopkins affiliate located in Baltimore, Maryland, that provides in-patient and out-patient medical care, community services, and school-based programs for children and adolescents with learning disabilities, as well as disorders of the brain, spinal cord, and musculoskeletal system. The Institute provides services for children with developmental concerns mild to severe and is involved in research of various disorders, including new interventions and earlier diagnosis.

This disability rights timeline lists events relating to the civil rights of people with disabilities in the United States of America, including court decisions, the passage of legislation, activists' actions, significant abuses of people with disabilities, and the founding of various organizations. Although the disability rights movement itself began in the 1960s, advocacy for the rights of people with disabilities started much earlier and continues to the present.

Puberty blockers are medicines used to postpone puberty in children. The most commonly used puberty blockers are gonadotropin-releasing hormone (GnRH) agonists, which suppress the production of sex hormones, including testosterone and estrogen. In addition to their use in treating precocious puberty, which involves puberty occurring at an unusually early age in children, puberty blockers are also used for transgender children to delay the development of unwanted sex characteristics, so as to allow transgender youth more time to explore their gender identity.

<span class="mw-page-title-main">Mithu Alur</span> Indian researcher, writer, and disability rights activist

Mithu Alur is the founder chairperson of The Spastic Society of India – now rechristened ADAPT – Able Disable All People Together. She is an educator, disability rights activist, researcher, writer and published author on issues concerning people with disability in India.

Selna Lucille Kaplan was an American pediatric endocrinologist and a professor of pediatrics at the University of California, San Francisco. She led the first American clinical trials of growth hormone treatment.

<span class="mw-page-title-main">Disability in France</span>

Approximately 12 million French citizens are affected by disability. The history of disability activism in France dates back to the French Revolution when the national obligation to help disabled citizens was recognized, but it was "unclear whether or not such assistance should be public or private." Disabled civilians began to form the first associations to demand equal rights and integration in the workforce after the First World War. Between 1940 and 1945, 45,000 people with intellectual disabilities died from neglect in French psychiatric asylums. After the Second World War, parents of disabled children and charities created specialized institutions for disabled children for whom school was not accessible. In 2018, the French Government began to roll out a disability policy which aimed to increase the allowance for disabled adults to €900 per month, improve the digital accessibility of public services, and develop easy-to-read and understand language among other goals.

<span class="mw-page-title-main">Impact of the COVID-19 pandemic on people with disabilities</span>

Individuals with disabilities are more susceptible to contracting COVID-19 and have higher mortality rates compared to those without disabilities. This is particularly true for people with intellectual and developmental disabilities, those residing in care facilities, and women with disabilities. Individuals with disabilities face heightened risks of mental health issues related to the pandemic, such as increased feelings of loneliness and isolation. They may also be more vulnerable to domestic violence and abuse during the pandemic. People with disabilities are more likely to experience unemployment as a result of the pandemic and may require changes to the types of accommodations they require for work. Children with disabilities experience complications in their educational programming. Remote learning poses a host of challenges for children with disabilities, including disruptions to physical and occupational therapies and access to assistive technologies.

Abha Khetarpal is an Indian disability rights activist and counsellor based in New Delhi, India. She is the founder of Cross The Hurdles – a counselling/educational resource website and mobile application designed for people with disabilities.

References

  1. ↑ "A slide summary of the "Ashley Treatment"" (PDF). Archived (PDF) from the original on 13 May 2008. Retrieved 2008-05-06.
  2. 1 2 3 4 5 6 7 "The "Ashley Treatment" blog" . Retrieved 2007-01-11.
  3. ↑ Gunther, DF; Diekema, DS (2006). "Attenuating growth in children with profound developmental disability: a new approach to an old dilemma". Archives of Pediatrics & Adolescent Medicine. 160 (10): 1013–7. doi:10.1001/archpedi.160.10.1013. PMID   17018459.
  4. ↑ Field, Genevieve (2016-03-22). "Should Parents of Children With Severe Disabilities Be Allowed to Stop Their Growth?". The New York Times. ISSN   0362-4331 . Retrieved 2023-07-11.
  5. ↑ "'Pillow angel' parents answer CNN's questions". CNN. 2008-03-12.
  6. ↑ Pilkington, Ed (2012-03-15). "The Ashley treatment: 'Her life is as good as we can possibly make it'". The Guardian.
  7. ↑ McVeigh, Karen (2012-03-16). "The 'Ashley treatment': Erica's story". The Guardian.
  8. ↑ McVeigh, Karen (2012-03-16). "Growth attenuation treatment: Tom, the first boy to undergo procedure". The Guardian.
  9. ↑ ""Sunday" meets parents who decided to keep their daughter small through a rare treatment". Sunday TV station in New Zealand. 2014-05-17.
  10. ↑ Chisholm, Donna (June 2014). "Let's Talk About Charley". North & South . pp. 66–75.
  11. ↑ Pollock, Allison J; Fost, Norman; Allen, David B (July 2015). "Growth attenuation therapy: practice and perspectives of paediatric endocrinologists". Archives of Disease in Childhood. 100 (12): 1185. doi:10.1136/archdischild-2015-309130. PMC   4762252 . PMID   26203123.
  12. ↑ "Growth Attenuation Therapy: Practice & Perspectives of Pediatric Endocrinologists (summary slide)" (PDF). Department of Pediatrics, University of Wisconsin School of Medicine & Public Health. 2014-07-21.
  13. ↑ Allen, David B; Kappy, Michael; Diekema, Douglas; Fost, Norman (June 2009). "Growth-Attenuation Therapy: Principles for Practice". Pediatrics. 123 (6): 1556–1561. doi:10.1542/peds.2008-2951. PMID   19482768. S2CID   37394675.
  14. ↑ Diekema, Douglas; Fost, Norman (January 2010). "Ashley Revisited: A Response to the Critics". The American Journal of Bioethics. 10 (1): 30–44. doi: 10.1080/15265160903469336 . PMID   20077335. S2CID   205858150.
  15. ↑ Burkholder, Amy Disabled girl's parents defend growth-stunting treatment, CNN, retrieved 2008-03-12
  16. ↑ Caplan, Arthur (2007-01-05). "Is 'Peter Pan' treatment a moral choice?". NBC News. Retrieved 2007-01-08.
  17. ↑ Mims, Christopher (2007-01-05). "The Pillow Angel Case--Three Bioethicists Weigh In". Scientific American. Retrieved 2014-08-23.
  18. ↑ "Not Dead Yet statement on "growth attenuation" experimentation". Not Dead Yet. 2006-01-06. Archived from the original on 2007-06-12. Retrieved 2007-01-29.
  19. ↑ Smock, Amber (2007-01-10). "Feminist Response in Disability Activism (FRIDA) to lead "Ashley treatment action" at the American Medical Association Headquarters". FRIDA blog. FRIDA. Retrieved 2007-01-29.
  20. ↑ "Modify the System, Not the Person". DREDF. 2007-01-07.
  21. ↑ Dvorsky, George (2006-11-06). "Helping families care for the helpless". IEET. Archived from the original on 2007-08-21. Retrieved 2009-09-03.
  22. ↑ Singer, Peter (2007-01-26). "A Convenient Truth". New York Times.
  23. ↑ Fost, Norm (2007-01-12). "CNN LARRY KING LIVE on the Ashley Treatment". CNN.
  24. ↑ Diekema, Doug (2007-01-11). "Ethicist in Ashley case answers questions". CNN.
  25. ↑ "A genuine moral dilemma, say doctors". The Daily Telegraph . 2007-01-05. Retrieved 2007-01-08.[ dead link ]
  26. ↑ Schafer, Arthur (2007-01-14). "Shortening Ashley: Was radical surgery to control young girl's growth justified?". Winnipeg Free Press. Retrieved 2007-01-29.
  27. ↑ Hingsburger, Dave (2007-01-13). "Ashley's treatment". Chewing the Fat. Retrieved 2007-01-29.
  28. ↑ Wellar, Keenan (2007-01-24). "Disabled girl has rights, too" (PDF). Ottawa Citizen . Archived from the original (PDF) on 2011-07-06. Retrieved 2007-01-29.
  29. ↑ Carlson, David R.; Dorfman, Deborah A. (2007-05-08). "Investigative Report Regarding the "Ashley Treatment"" (PDF). Washington Protection and Advocacy System (a/k/a Disability Rights Washington). Archived from the original (PDF) on June 17, 2007. Retrieved 2007-05-08.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.